Correlation Between the Variability of Different Obesity Indices and Diabetic Kidney Disease: A Retrospective Cohort Study Based on Populations in Taiwan

References

• Sugahara M, Pak WLW, Tanaka T, Tang SCW, Nangaku M. Update on diagnosis, pathophysiology, and management of diabetic kidney disease. Nephrology. 2021;26(6):491–500. doi:10.1111/nep.13860
   PubMed Web of Science ®Google Scholar
• Chen Y, Lee K, Ni Z, He JC. Diabetic kidney disease: challenges, advances, and opportunities. Kidney Dis. 2020;6(4):215–225. doi:10.1159/000506634
   Google Scholar
• Lin YK, Gao B, Liu L, et al. The prevalence of diabetic microvascular complications in China and the USA. Curr Diab Rep. 2021;21(6):16. doi:10.1007/s11892-021-01387-3
   PubMed Web of Science ®Google Scholar
• Kovesdy CP, Furth S, Zoccali C; World Kidney Day Steering Committee. Obesity and kidney disease: hidden consequences of the epidemic. Physiol Int. 2017;104(1):1–14. doi:10.1556/2060.104.2017.1.9
   PubMed Web of Science ®Google Scholar
• Xu T, Sheng Z, Yao L. Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment. Front Med. 2017;11(3):340–348. doi:10.1007/s11684-017-0570-3
   PubMed Web of Science ®Google Scholar
• Zhao Q, Yi X, Wang Z. Meta-analysis of the relationship between abdominal obesity and diabetic kidney disease in type 2 diabetic patients. Obes Facts. 2021;14(4):338–345. doi:10.1159/000516391
   PubMed Web of Science ®Google Scholar
• Duan JY, Duan GC, Wang CJ, et al. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in a central Chinese urban population: a cross-sectional survey. BMC Nephrol. 2020;21(1):115. doi:10.1186/s12882-020-01761-5
   PubMed Web of Science ®Google Scholar
• Man REK, Gan ATL, Fenwick EK, et al. The relationship between generalized and abdominal obesity with diabetic kidney disease in type 2 diabetes: a multiethnic asian study and meta-analysis. Nutrients. 2018;10(11):1685.
   PubMed Web of Science ®Google Scholar
• Haslam DW, James WP. Obesity. Lancet. 2005;366(9492):1197–1209. doi:10.1016/S0140-6736(05)67483-1
   PubMed Web of Science ®Google Scholar
• Maskarinec G, Raquinio PA, Setiawan VW, et al. Biomarker-based visceral adiposity score and incident type 2 diabetes in the multiethnic cohort. Ann Epidemiol. 2021;63:29–34. doi:10.1016/j.annepidem.2021.07.002
   PubMed Web of Science ®Google Scholar
• Fang H, Berg E, Cheng X, Shen W. How to best assess abdominal obesity. Curr Opin Clin Nutr Metab Care. 2018;21(5):360–365. doi:10.1097/MCO.0000000000000485
   PubMed Web of Science ®Google Scholar
• Omura-Ohata Y, Son C, Makino H, et al. Efficacy of visceral fat estimation by dual bioelectrical impedance analysis in detecting cardiovascular risk factors in patients with type 2 diabetes. Cardiovasc Diabetol. 2019;18(1):137. doi:10.1186/s12933-019-0941-y
   PubMed Web of Science ®Google Scholar
• Dong Y, Bai L, Cai R, Zhou J, Ding W. Visceral adiposity index performed better than traditional adiposity indicators in predicting unhealthy metabolic phenotype among Chinese children and adolescents. Sci Rep. 2021;11(1):23850. doi:10.1038/s41598-021-03311-x
   PubMed Web of Science ®Google Scholar
• Nunes SH, Nogueira Saad MA, da Cruz Filho RA, et al. Is lipid accumulation product a better cardiovascular risk predictor in elderly individuals than anthropometric measures? Rev Port Cardiol. 2021;40(8):539–544. doi:10.1016/j.repce.2020.09.007
   PubMedGoogle Scholar
• Mazidi M, Kengne AP, Katsiki N, Mikhailidis DP, Banach M. Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance. J Diabetes Complications. 2018;32(3):266–270. doi:10.1016/j.jdiacomp.2017.10.007
   PubMed Web of Science ®Google Scholar
• Thomas DM, Bredlau C, Bosy-Westphal A, et al. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obesity. 2013;21(11):2264–2271. doi:10.1002/oby.20408
   PubMed Web of Science ®Google Scholar
• Tian T, Zhang J, Zhu Q, Xie W, Wang Y, Dai Y. Predicting value of five anthropometric measures in metabolic syndrome among Jiangsu Province, China. BMC Public Health. 2020;20(1):1317. doi:10.1186/s12889-020-09423-9
   PubMed Web of Science ®Google Scholar
• Rico-Martín S, Calderón-García JF, Sánchez-Rey P, Franco-Antonio C, Martínez Alvarez M, Sánchez Muñoz-Torrero JF. Effectiveness of body roundness index in predicting metabolic syndrome: a systematic review and meta-analysis. Obes Rev. 2020;21(7):e13023. doi:10.1111/obr.13023
   PubMed Web of Science ®Google Scholar
• Sun Z, Wang K, Miller JD, Yuan X, Lee YJ, Lou Q. External validation of the risk prediction model for early diabetic kidney disease in Taiwan population: a retrospective cohort study. BMJ Open. 2022;12(12):e059139. doi:10.1136/bmjopen-2021-059139
   PubMed Web of Science ®Google Scholar
• Harreiter J, Roden M. Diabetes mellitus – definition, klassifikation, Diagnose, screening und prävention (update 2019) [Diabetes mellitus-definition, classification, diagnosis, screening and prevention (update 2019)]. Wien Klin Wochenschr. 2019;131(Suppl 1):6–15. German. doi:10.1007/s00508-019-1450-4
   PubMedGoogle Scholar
• Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–992. doi:10.1053/j.ajkd.2008.12.034
   PubMed Web of Science ®Google Scholar
• Selby NM, Taal MW. An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metab. 2020;22(Suppl 1):3–15. doi:10.1111/dom.14007
   PubMed Web of Science ®Google Scholar
• Microvascular Complications Group of Chinese Diabetes Society. Clinical guideline for the prevention and treatment of diabetic kidney disease in China (2021 edition), Chin J Diabetes Mellit. 2021;13(8):762–784. Chinese. doi:10.3760/cma.j.cn115791-20210706-00369
   Google Scholar
• Ou YL, Lee MY, Lin IT, Wen WL, Hsu WH, Chen SC. Obesity-related indices are associated with albuminuria and advanced kidney disease in type 2 diabetes mellitus. Ren Fail. 2021;43(1):1250–1258. doi:10.1080/0886022X.2021.1969247
   PubMed Web of Science ®Google Scholar
• Eder S, Leierer J, Kerschbaum J, et al. Guidelines and clinical practice at the primary level of healthcare in patients with type 2 diabetes mellitus with and without kidney disease in five European countries. Diab Vasc Dis Res. 2019;16(1):47–56. doi:10.1177/1479164118795559
   PubMed Web of Science ®Google Scholar
• Afkarian M, Zelnick LR, Hall YN, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988–2014. JAMA. 2016;316(6):602–610. doi:10.1001/jama.2016.10924
   PubMed Web of Science ®Google Scholar
• Xia L, Cheng L, Jiang T, et al. Estimation of the prevalence of type 2 diabetes in combination with diabetic kidney disease and identification of the associated factors in patients attending primary hospitals in Anhui Province, China. J Int Med Res. 2021;49(10):3000605211051225. doi:10.1177/03000605211051225
   Web of Science ®Google Scholar
• Wan H, Wang Y, Xiang Q, et al. Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference. Cardiovasc Diabetol. 2020;19(1):118. doi:10.1186/s12933-020-01095-4
   PubMed Web of Science ®Google Scholar
• Chagnac A, Zingerman B, Rozen-Zvi B, Herman-Edelstein M. Consequences of glomerular hyperfiltration: the role of physical forces in the pathogenesis of chronic kidney disease in diabetes and obesity. Nephron. 2019;143(1):38–42. doi:10.1159/000499486
   PubMed Web of Science ®Google Scholar
• Nehus E. Obesity and chronic kidney disease. Curr Opin Pediatr. 2018;30(2):241–246. doi:10.1097/MOP.0000000000000586
   PubMed Web of Science ®Google Scholar
• Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004;15(11):2792–2800. doi:10.1097/01.ASN.0000141966.69934.21
   PubMed Web of Science ®Google Scholar
• Mohammad NS, Nazli R, Zafar H, Fatima S. Effects of lipid based multiple micronutrients Supplement on the birth outcome of underweight pre-eclamptic women: a randomized clinical trial. Pak J Med Sci. 2022;38(1):219–226. doi:10.12669/pjms.38.1.4396
   PubMed Web of Science ®Google Scholar
• Huang R, Cheng Z, Jin X, et al. Usefulness of four surrogate indexes of insulin resistance in middle-aged population in Hefei, China. Ann Med. 2022;54(1):622–632. doi:10.1080/07853890.2022.2039956
   PubMed Web of Science ®Google Scholar
• Xia MF, Lin HD, Chen LY, et al. Association of visceral adiposity and its longitudinal increase with the risk of diabetes in Chinese adults: a prospective cohort study. Diabetes Metab Res Rev. 2018;34(7):e3048. doi:10.1002/dmrr.3048
   PubMed Web of Science ®Google Scholar
• Yang J, Wang F, Han X, et al. Different anthropometric indices and incident risk of hypertension in elderly population: a prospective cohort study. Zhonghua Yu Fang Yi Xue Za Zhi. 2019;53(3):272–278. doi:10.3760/cma.j.issn.0253-9624.2019.03.007
   PubMedGoogle Scholar
• Ceriello A, De Cosmo S, Rossi MC, et al. Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes. Diabetes Obes Metab. 2017;19(11):1570–1578. doi:10.1111/dom.12976
   PubMed Web of Science ®Google Scholar
• Hukportie DN, Li FR, Zhou R, Zheng JZ, Wu XX, Wu XB. Waist circumference and body mass index variability and incident diabetic microvascular complications: a post hoc analysis of ACCORD Trial. Diabetes Metab J. 2022;46(5):767–780. doi:10.4093/dmj.2021.0258
   PubMed Web of Science ®Google Scholar